Loading...

PE anti-mouse/human CD11b Antibody

Pricing & Availability
Clone
M1/70 (See other available formats)
Regulatory Status
RUO
Other Names
αM integrin, Mac-1, Mo1, CR3, Ly-40, C3biR, ITGAM
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
M170_PE_042706
C57BL/6 mouse bone marrow cells were stained with CD11b (clone M1/70) PE (filled histogram) or rat IgG2b, κ PE isotype control (open histogram) (gated on total cells).
  • M170_PE_042706
    C57BL/6 mouse bone marrow cells were stained with CD11b (clone M1/70) PE (filled histogram) or rat IgG2b, κ PE isotype control (open histogram) (gated on total cells).
  • M170_PE_CD11b_Antibody_IHC_031413
    Fixed whole mount mouse spleen was stained with Alexa Fluor® 488 F4/80 (red) (clone BM8), Brilliant Violet 421™ CD3ε (green) (clone 145-2C11), and PE CD11b (blue) (clone M1/70). Isotype controls at the same concentrations were used for the negative control. Cells were mounted in Prolong Gold and imaged with a Leica SP8 confocal. Image courtesy of Grzegorz Chodaczek and Zbigniew Mikulski at LIAI.
Compare all formats See PE spectral data See more IHC data...
Cat # Size Price Save
101207 50 µg ¥12,320
101208 200 µg ¥30,000
Description

CD11b is a 170 kD glycoprotein also known as αM integrin, Mac-1 α subunit, Mol, CR3, and Ly-40. CD11b is a member of the integrin family, primarily expressed on granulocytes, monocytes/macrophages, dendritic cells, NK cells, and subsets of T and B cells. CD11b non-covalently associates with CD18 (β2 integrin) to form Mac-1. Mac-1 plays an important role in cell-cell interaction by binding its ligands ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, and fibrinogen.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse, Human, Cynomolgus, Rhesus
Reported Reactivity
Chimpanzee, Baboon, Rabbit
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
C57BL/10 splenocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/mL
Storage & Handling
The CD11b antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
IHC - Verified
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µL volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Clone M1/70 has been verified for immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F).

Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1,4, in vitro blocking3,9,12, depletion2,8, immunofluorescence microscopy6,7,10, immunohistochemistry of acetone-fixed frozen sections5,11-13, and spatial biology (IBEX)35,36. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) (Cat. No. 101248).

Additional Product Notes

View more applications data for this product in our Scientific Poster Library.

Application References

(PubMed link indicates BioLegend citation)
  1. Springer T, et al. 1978. Eur. J. Immunol. 8:539. (IP)
  2. Ault K and Springer T. 1981. J. Immunol. 126:359. (Deplete)
  3. Springer TA, et al. 1982. Immunol. Rev. 68:171. (Block)
  4. Ho MK and Springer TA. 1983. J. Biol. Chem. 258:2766. (IP)
  5. Flotte TJ, et al. 1983. Am. J. Pathol. 111:112. (IHC)
  6. Noel GJ, et al. 1990. J. Clin. Invest. 85:208. (IF)
  7. Allen LA and Aderem A. 1996. J. Exp. Med. 184:627 (IF)
  8. D'Amico A and Wu L. 2003. J. Exp. Med. 198:293. (Deplete)
  9. Brickson SJ, et al. 2003. Appl Physiol. 95:969. (Block)
  10. Clatworthy MR and Smith KG. 2004. J. Exp. Med. 199:717. (IF)
  11. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  12. Zhang Y, et al. 2002. J. Immunol. 168:3088. (IHC)
  13. Iwasaki A and Kelsall BL. 2001. J. Immunol. 166:4884 (IHC, FC)
  14. Tailleux L. 2003. J. Exp. Med. 197:121. (Block, FC)
  15. Olver S, et al. 2006. Cancer Research 66:571. (FC)
  16. Tan SL, et al. 2006. J. Immunol. 176:2872. (FC) PubMed
  17. Ponomarev ED, et al. 2006. J. Immunol. 176:1402. (FC)
  18. Dzhagalov I, et al. 2007. Blood 109:1620. (FC)
  19. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  20. Rasmussen JW, et al. 2006. Infect. Immun.74:6590. PubMed
  21. Napimoga MH, et al. 2008. J. Immunol. 180:609. PubMed
  22. Elqaraz-Carmon V, et al. 2008. J. Lipid. Res. 49:1894. PubMed
  23. Kim DD, et al. 2008. Blood 112:1109. PubMed
  24. Guo Y, et al. 2008. Blood 112:480. PubMed
  25. Norian LA, et al. 2009. Cancer Res. 69:3086. (FC) PubMed
  26. Baumgartner CK, et al. 2010. J. Immunol. 184:573. PubMed
  27. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  28. Whiteland J, et al. 1995. J. Histochem. Cytochem. 43:313. (IHC)
  29. Weber GF, et al. 2014. J Exp Med. 211:1243. PubMed
  30. Ashok A, et al. 2015. Toxicol Sci. 143:64. PubMed
  31. Price PJ, et al. 2015. J Immunol. 194:1164. PubMed
  32. Doni A, et al. 2015. J Exp Med. 212:905. PubMed
  33. Ferreira R, et al. 2016. J Infect Dis. 213: 669 - 673. PubMed
  34. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  35. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  36. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Guo H, Cooper S, Friedman A, et al. 2017. PLoS One. 10.1371/journal.pone.0150809. PubMed
  2. Chida J, et al. 2020. PLoS Pathog. 16:e1008823. PubMed
  3. Guo Y, et al. 2021. Exp Ther Med. 353:21. PubMed
  4. Ho YH, et al. 2019. Cell Stem Cell. 25:407. PubMed
  5. Ying W, et al. 2019. Cell Metab. 29:457. PubMed
  6. Kisielow J, et al. 2019. Nat Immunol. 1.286111111. PubMed
  7. Li A, et al. 2020. Oncol Lett. 1.899305556. PubMed
  8. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  9. Kuo PC, et al. 2021. Brain Commun. 3:fcab187. PubMed
  10. Zhao D, et al. 2021. Innate Immun. 27:533. PubMed
  11. Rosina M, et al. 2022. Cell Metab. 34:533. PubMed
  12. Nigam S, et al. 2020. Mol Imaging Biol. 22:685. PubMed
  13. Hu K, et al. 2022. J Extracell Vesicles. 11:e12199. PubMed
  14. Lei G, et al. 2016. Antimicrob Agents Chemother. 60: 1289 - 1297. PubMed
  15. Viny AD, et al. 2019. Cell Stem Cell. 25:682. PubMed
  16. Jones NM, et al. 2019. BMC Cancer. 1.127777778. PubMed
  17. Wu N, et al. 2020. Cell Rep. 30:1129. PubMed
  18. Bhatt K, et al. 2018. mSphere. 3:e00352. PubMed
  19. Baryawno N et al. 2019. Cell. 177(7):1915-1932 . PubMed
  20. Abels ER et al. 2019. Cell Rep. 28(12):3105-3119 . PubMed
  21. Paris J et al. 2019. Cell Stem Cell. 25(1):137-148 . PubMed
  22. Prajeeth C,et al. 2017. J Neuroinflammation.. 10.1186/s12974-017-0978-3. PubMed
  23. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  24. Yan F, et al. 2022. Cancer Discov. 12:792. PubMed
  25. Lee S, et al. 2021. JCI Insight. 6:. PubMed
  26. Zhao X, et al. 2022. Front Mol Biosci. 9:786864. PubMed
  27. Deng Y, et al. 2021. Acta Pharmacol Sin. 42:149. PubMed
  28. Pan J, et al. 2021. Mol Ther Nucleic Acids. 26:970. PubMed
  29. Li X, et al. 2015. Proc Natl Acad Sci U S A. 112:6080. PubMed
  30. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  31. Dumas SJ, et al. 2021. STAR Protocols. 2(3):100523. PubMed
  32. Zhang Z, et al. 2020. J Immunol. 204:3400. PubMed
  33. Gonçalves NP, et al. 2017. J Neuroinflammation. 14:115. PubMed
  34. Yamauchi T et al. 2018. Cancer cell. 33(3):386-400 . PubMed
  35. Xiao X, et al. 2020. J Hematol Oncol. 0.597222222. PubMed
  36. Elkabets M, et al. 2009. J Immunol. 182:4874. PubMed
  37. Sauter M, et al. 2022. iScience. 25:103677. PubMed
  38. Conforti A, et al. 2021. PLoS One. 16:e0259894. PubMed
  39. Götz P, et al. 2022. Int J Mol Sci. 23:. PubMed
  40. Adachi Y, et al. 2022. Nat Commun. 13:5117. PubMed
  41. Forte E, et al. 2020. J Cell Mol Med. . PubMed
  42. Earnest JT, et al. 2021. Cell Reports. 35(1):108962. PubMed
  43. Jard T, et al. 2020. Cell Stem Cell. 27(4):646-662.e7. PubMed
  44. Forte D, et al. 2020. Cell Metab. 32:829. PubMed
  45. Coppo M, et al. 2016. Nat Commun. 7:12254. PubMed
  46. Wang X, et al. 2016. PLoS Pathog. 12: 1005367. PubMed
  47. Hiraishi Y, et al. 2018. Sci Rep. 8:18052. PubMed
  48. Wu R, et al. 2019. J Cell Mol Med. 24:1684. PubMed
  49. Llewellyn GN, et al. 2018. J Neurovirol. 24:192. PubMed
  50. Sun Y et al. 2018. Cancer cell. 34(4):643-658 . PubMed
  51. Shears RK, et al. 2020. J Allergy Clin Immunol. 145:1272. PubMed
  52. Chen X, et al. 2021. Cell Death Differ. 28:1237. PubMed
  53. Stolp B, et al. 2022. Cell Rep. 38:110387. PubMed
  54. Craver BM, et al. 2020. Blood Adv. 4:312. PubMed
  55. Price J, et al. 2015. Diabetes. 64: 3521 - 3531. PubMed
  56. Kalucka J, et al. 2020. Cell. 764:180. PubMed
  57. Turkowski K, et al. 2017. Glia. 10.1002/glia.23234. PubMed
  58. Wiese A, et al. 2017. PLoS One. 10.1371/journal.pone.0184956. PubMed
  59. Hengyou Weng et al. 2018. Cell stem cell. 22(2):191-205 . PubMed
  60. Nakagawa S et al. 2017. Cell host & microbe. 22(5):667-677 . PubMed
  61. Swidergall M, et al. 2019. Cell Rep. 28:423. PubMed
  62. Ganeshan K et al. 2019. Cell. 177(2):399-413 . PubMed
  63. LaFleur MW, et al. 2019. Nat Immunol. 20:1335. PubMed
  64. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  65. Fukushima T, et al. 2019. Cell Rep. 29:4144. PubMed
  66. Joseph R, et al. 2021. Br J Cancer. 125:176. PubMed
  67. Park JA, et al. 2021. J Hematol Oncol. 14:142. PubMed
  68. Wang Y, et al. 2022. Acta Pharm Sin B. 12:262. PubMed
  69. Zhou HF, et al. 2022. Front Pharmacol. 13:778755. PubMed
  70. Chen F, et al. 2022. Evid Based Complement Alternat Med. 2022:1240242. PubMed
  71. Xu F, et al. 2022. Cell Death Discov. 8:142. PubMed
  72. Haugh KA, et al. 2021. eLife. 0.416666666666667. PubMed
  73. Perner C, et al. 2020. Immunity. 53(5):1063-1077.e7. PubMed
  74. Endo Y, et al. 2020. FASEB J. 34:16086. PubMed
  75. Diao N, et al. 2016. Sci Rep. 6:34672. PubMed
  76. Huang L, et al. 2016. J Biol Chem. 291: 6232 - 6244. PubMed
  77. Sharma S, et al. 2015. J Immunol. 194:5529. PubMed
  78. Pan J, et al. 2020. J Neuroinflammation. 17:97. PubMed
  79. Paraiso HC, et al. 2018. J Neuroinflammation. 0.694444444. PubMed
  80. Pan W et al. 2017. Immunity. 47(2):284-297 . PubMed
  81. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
  82. Hammond TR, et al. 2019. Immunity. 50:253. PubMed
  83. Wang C, et al. 2017. J Immunol. 10.4049/jimmunol.1700671. PubMed
  84. Li K, et al. 2022. J Immunother Cancer. 10:. PubMed
  85. Hongu T, et al. 2022. Nat Cancer. 3:486. PubMed
  86. Rogawski DS, et al. 2021. Nat Commun. 12:2792. PubMed
  87. Trenevska I, et al. 2021. PLoS One. 16:e0249967. PubMed
  88. Gordon RA, et al. 2020. PLoS One. 15:e0226396. PubMed
  89. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  90. Xiao Z, et al. 2015. Cancer Lett. 360:302. PubMed
  91. Donley DW, et al. 2021. PLOS ONE. 16(5):e0250606. PubMed
  92. Jassinskaja M, et al. 2021. Cell Reports. 34(12):108894. PubMed
  93. Ratitong B, et al. 2021. Cell Reports. 35(7):109139. PubMed
  94. An J,et al. 2017. Sci Rep.. 10.1038/s41598-017-13629-0. PubMed
  95. Wang L, et al. 2017. Front Immunol.. 10.3389/fimmu.2017.01754. PubMed
  96. Kunimoto H, et al. 2018. Cancer Cell. 33:44. PubMed
  97. Parada-Kusz M, et al. 2018. Dis Model Mech. 11:. PubMed
  98. Zhang S, et al. 2019. Mol Med Rep. 19:5377. PubMed
  99. Shimokawa C et al. 2017. Immunity. 46(5):863-874 . PubMed
  100. Riffelmacher T et al. 2017. Immunity. 47(3):466-480 . PubMed
  101. Nakaya M, et al. 2017. J Clin Invest. 127:383. PubMed
  102. Mayo L, et al. 2008. J Immunol. 181:92. PubMed
  103. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  104. Zheng Y, et al. 2022. Front Pharmacol. 12:816032. PubMed
  105. Dane EL, et al. 2022. Nat Mater. 21:710. PubMed
  106. Guo W, et al. 2022. J Immunother Cancer. 10:. PubMed
  107. Zhang X, et al. 2022. Cells. 11:. PubMed
  108. Jin R, et al. 2020. Mol Cancer Ther. . PubMed
  109. Nguyen TKT, et al. 2020. Am J Pathol. 286:190. PubMed
  110. Gereke M, et al. 2012. J Vis Exp. 70: 4322. PubMed
  111. Pang D, et al. 2015. Clin Transl Immunology. 4: e41. PubMed
  112. Bertino P, et al. 2019. Oncoimmunology. 8:1601482. PubMed
  113. Keshavarz M, et al. 2020. Virol J. 17:64. PubMed
  114. He L, et al. 2019. iScience. 0.790972222. PubMed
  115. Frazier T, et al. 2018. Adipocyte. 0.41875. PubMed
  116. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  117. Liu D et al. 2019. Immunity. 51(1):64-76 . PubMed
  118. Anstine L,et al. 2017. J Am Heart Assoc.. 10.1161/JAHA.117.007097. PubMed
  119. Kotaki R, et al. 2020. Sci Rep. 10:13554. PubMed
  120. Wu L, et al. 2022. Theranostics. 12:842. PubMed
  121. Ajina R, et al. 2021. Cancer Immunol Res. 9:386. PubMed
  122. Jaworska K, et al. 2015. J Immunol. 194:325. PubMed
  123. Chen Y, et al. 2015. PLoS One. 10: 0135217. PubMed
  124. Li L, et al. 2015. J Am Soc Nephrol. 26: 2183-2197. PubMed
  125. Souza COS, et al. 2021. iScience. 24(6):102548. PubMed
  126. Hönes J, et al. 2017. Sci Rep. . 10.1038/s41598-017-15866-9. PubMed
  127. Niemann J, et al. 2019. Nat Commun. 10:3236. PubMed
  128. Hou M, et al. 2020. Stem Cell Res Ther. 11:55. PubMed
  129. Mao FY, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:395. PubMed
  130. Hildebrand KM, et al. 2021. PLoS One. 16:e0253864. PubMed
  131. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  132. Malekghasemi S, et al. 2020. Cell Biol Int. 44:2031. PubMed
  133. Han D, et al. 2021. J Immunol Res. 6688053:2021. PubMed
  134. Nguyen GT, et al. 2021. iScience. 24(8):102871. PubMed
  135. Garg M, et al. 2021. Cell Reports. 34(6):108736. PubMed
  136. Cao DY, et al. 2020. J Biol Chem. 295:1369. PubMed
  137. Moorlag SJCFM, et al. 2020. Cell Rep. 33:108387. PubMed
  138. Koshida R, et al. 2015. Biochem Biophys Res Commun. 463: 109-115. PubMed
  139. Textor A, et al. 2014. Cancer Res. 74:6769. PubMed
  140. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  141. Luong-Gardiol N, et al. 2019. Cancer Cell. 35:649. PubMed
  142. Murray C, et al. 2018. Lab Chip. 18:2396. PubMed
  143. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  144. Baik JE, et al. 2022. Clin Transl Med. 12:e758. PubMed
  145. Di Martino L, et al. 2021. Cell Mol Gastroenterol Hepatol. 13:901. PubMed
  146. Zhang C, et al. 2022. Nat Commun. 13:3468. PubMed
  147. Lin S, et al. 2022. Nat Commun. 13:3301. PubMed
  148. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
  149. Kan X, et al. 2015. Cardiovasc Res. 10.1093/cvr/cvv255. PubMed
  150. Mizuno T, et al. 2017. Sci Rep. 7:42714. PubMed
  151. Holokai L, et al. 2020. Cancers (Basel). 12:00. PubMed
  152. Xiang W, et al. 2018. Nat Commun. 9:2574. PubMed
  153. LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
  154. He J, et al. 2019. J Clin Invest. 130. PubMed
  155. Huang Y, et al. 2019. Cancer Cell. 35:677. PubMed
  156. Ruiz de Azua I, et al. 2017. J Clin Invest. 127:4148. PubMed
  157. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  158. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  159. Haas MS, et al. 2020. Mol Cancer Res. 19:717. PubMed
  160. Jorapur A, et al. 2022. PLoS Pathog. 18:e1010200. PubMed
  161. Yang Y, et al. 2022. Elife. 11:. PubMed
  162. Bolkhovitina EL, et al. 2022. Int J Mol Sci. 23: . PubMed
  163. Colombo M, et al. 2022. iScience. 25:105042. PubMed
  164. Koikawa K, et al. 2021. Cell. 184:4753. PubMed
  165. Sokol L, et al. 2021. STAR Protocols. 2(2):100489. PubMed
  166. Yamakawa D, et al. 2021. Cell Reports. 34(10):108817. PubMed
  167. Troutman TD, et al. 2021. STAR Protocols. 2(1):100363. PubMed
  168. Wang L, et al. 2012. PLoS One. 7:e40056. PubMed
  169. Staschke K, et al. 2009. J Immunol. 183:568. PubMed
  170. Challa TD, et al. 2020. Cell Reports. 30(10):3424-3433. PubMed
  171. Minuesa G, et al. 2019. Nat Commun. 10:2691. PubMed
  172. Zhou J, et al. 2019. Nat Commun. 10:2427. PubMed
  173. Kubota S, et al. 2019. Nat Commun. 10:1653. PubMed
  174. Wang Q, et al. 2018. Int J Biol Sci. 14:147. PubMed
  175. Perez-Garcia CG, et al. 2022. Mol Ther Nucleic Acids. 28:87. PubMed
  176. Uslu M, et al. 2020. J Cell Physiol. 235:9644. PubMed
  177. Zhai K, et al. 2021. Nat Cancer. 2:1136. PubMed
  178. Chiang HY, et al. 2022. Nat Commun. 13:874. PubMed
  179. Rashid MH, et al. 2021. Oncol Rep. 45:1171. PubMed
  180. Bermejo-Jambrina M, et al. 2021. EMBO J. 40:e106765. PubMed
  181. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  182. Langhauser F, et al. 2014. Stroke. 45:1799. PubMed
  183. Garcia-Bonilla L, et al. 2014. J Immunol. 193:2531. PubMed
  184. Favuzzi E, et al. 2021. Cell. 184(15):4048-4063.e32. PubMed
  185. Hsu Y, et al. 2017. Biochem Biophys Res Commun.. 10.1016/j.bbrc.2017.10.067. PubMed
  186. Subramanian K, et al. 2019. Nat Microbiol. 4:62. PubMed
  187. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  188. Gomez–Ospina N, et al. 2019. Nat Commun. 3.225694444. PubMed
  189. Tao Z, et al. 2019. Clin Cancer Res. 25:1113. PubMed
  190. Tan S, et al. 2006. J Immunol. 176:2872. PubMed
  191. Roy AG, et al. 2021. Int J Mol Sci. 22:. PubMed
  192. Liu S, et al. 2022. J Neuroinflammation. 19:35. PubMed
  193. Xiao Y, et al. 2022. Nat Commun. 13:758. PubMed
  194. Ali S, et al. 2021. PLoS One. 16:e0246646. PubMed
  195. Nuro-Gyina PK, et al. 2021. J Immunol. 207:868. PubMed
  196. Babagana M, et al. 2021. Aging (Albany NY). 13:19207. PubMed
  197. Li Q, et al. 2022. Front Cardiovasc Med. 9:872102. PubMed
  198. Dungan CM, et al. 2022. Aging Cell. 21:e13528. PubMed
  199. Li T, et al. 2021. J Neuroinflammation. 81:18. PubMed
  200. Guo M, et al. 2020. Brain. 1476:143. PubMed
  201. Houben T, et al. 2020. J Pathol. 251:429. PubMed
  202. Cai Z, et al. 2020. Cell Rep. 31:107816. PubMed
  203. Li L, et al. 2014. J Immunol. 192:1034. PubMed
  204. Demers M, et al. 2012. Proc Natl Acad Sci U S A. 109:13076. PubMed
  205. Gladow N, et al. 2020. PLoS One. 15:e0227734. PubMed
  206. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  207. Li YT, et al. 2019. Elife. 8:e47642. PubMed
  208. Luck H, et al. 2019. Nat Commun. 10:3650. PubMed
  209. Xiao G, et al. 2018. Cell. 173:470. PubMed
  210. Spangenberg E, et al. 2019. Nat Commun. 10:3758. PubMed
  211. Wu ZJ, et al. 2018. Int J Oncol. 52:1209. PubMed
  212. Szeifert V, et al. 2021. Front Immunol. 12:671995. PubMed
  213. Saber M, et al. 2021. J Neurosci Res. 99:1136. PubMed
  214. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  215. Berghoff SA, et al. 2021. Nat Neurosci. 24:47. PubMed
  216. Cao W, et al. 2021. Int J Mol Sci. 22:. PubMed
  217. Calle P, et al. 2021. Cells. 10:. PubMed
  218. Ding H, et al. 2016. Nat Commun. 7:11533. PubMed
  219. Yuan Y, et al. 2020. Front Physiol. 0.967361111. PubMed
  220. Varikuti S, et al. 2020. Br J Cancer. 122:1005. PubMed
  221. Toyohara T, et al. 2020. Cell Stem Cell. 27:147. PubMed
  222. Bennett FC, et al. 2018. Neuron. 98:1170. PubMed
  223. Zhang T, et al. 2018. PLoS One. 13:e0196571. PubMed
  224. Eisemann T, et al. 2019. Front Oncol. 9:187. PubMed
  225. Cá B, et al. 2019. Front Microbiol. 1.876388889. PubMed
  226. Dong Y, et al. 2021. Commun Biol. 4:560. PubMed
  227. Scheiblich H, et al. 2021. Cell. 184:5089. PubMed
  228. Tomimatsu M, et al. 2022. Sci Rep. 12:16656. PubMed
  229. Yokomizo-Nakano T, et al. 2020. Cancer Res. 80:2523. PubMed
  230. Lin KH, et al. 2020. Nat Genet. 52:408. PubMed
  231. Jablonski K, et al. 2015. PLoS One. 10: 0145342. PubMed
  232. Sanders K, et al. 2015. Cancer Immunol Res. 3: 891-901. PubMed
  233. Yuan C, et al. 2015. Biochem Biophys Res Commun. 464: 249-255. PubMed
  234. Resende M, et al. 2013. J Immunol. 191:262. PubMed
  235. Muri J, et al. 2020. Cell Reports. 29(9):2731-2744.e4.. PubMed
  236. Liu Y, et al. 2019. Sci Rep. 9:18970. PubMed
  237. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  238. Gerdes P, et al. 2022. Nat Commun. 13:7470. PubMed
  239. Düking T, et al. 2022. Sci Adv. 8:eabo7639. PubMed
  240. Wang X, et al. 2021. Cell. 184:5357. PubMed
  241. Li Y, et al. 2020. Theranostics. 10:2897. PubMed
  242. Xia D, et al. 2022. Mol Neurodegener. 17:41. PubMed
  243. Koide S, et al. 2022. iScience. 25:103603. PubMed
  244. Lin T, et al. 2021. PLoS Pathog. 17:e1009557. PubMed
  245. Casselli T, et al. 2021. PLoS Pathog. 17:e1009256. PubMed
  246. Kuo P, et al. 2016. J Am Heart Assoc. 5: 002610. PubMed
  247. Li K, et al. 2020. Nat Commun. 4.844444444. PubMed
  248. Avalle L, et al. 2020. Mol Ther Methods Clin Dev. 0.793055556. PubMed
  249. Zhou Q, et al. 2020. Nat Immunol. 1.393055556. PubMed
  250. Wang Z et al. 2019. Cell reports. 26(5):1273-1285 . PubMed
  251. Schaftenaar FH, et al. 2019. Sci Rep. 9:17391. PubMed
  252. Chao Y, et al. 2020. Sci Adv. 6:eaaz4204. PubMed
  253. Nguyen GT, et al. 2020. eLife. 9:e56656.. PubMed
  254. Hoyer FF, et al. 2020. Immunity. 51(5):899-914.e7.. PubMed
  255. Rodríguez L, et al. 2021. Biomolecules. 11: . PubMed
  256. Chen L, et al. 2021. Theranostics. 11:6668. PubMed
  257. Zhang A, et al. 2021. Theranostics. 11:3839. PubMed
  258. Zhai T, et al. 2020. Clin Exp Pharmacol Physiol. 47:677. PubMed
  259. Yang N, et al. 2022. Nat Commun. 13:2336. PubMed
  260. Saber M, et al. 2020. Eur J Neurosci. 52:2791. PubMed
  261. Garcia-Bonilla L, et al. 2015. J Neurosci. 35: 14783 - 14793. PubMed
  262. Baruch K, et al. 2015. EMBO J. 34: 1816 - 1828. PubMed
  263. Schmidt C, et al. 2005. J Immunol. 175:2286. PubMed
  264. Danne C et al. 2017. Cell host & microbe. 22(6):733-745 . PubMed
  265. Luo H, et al. 2019. Cell Rep. 26:945. PubMed
  266. Bozoglu T, et al. 2022. Adv Sci (Weinh). 9:e2103867. PubMed
  267. Shen H, et al. 2022. Nat Commun. 13:5013. PubMed
  268. Zhang X, et al. 2022. J Exp Clin Cancer Res. 41:246. PubMed
  269. Zhou Y, et al. 2022. Theranostics. 12:5488. PubMed
  270. Sheng D, et al. 2022. J Immunother Cancer. 10:. PubMed
  271. Bahmani B, et al. 2021. Nat Commun. 12:1999. PubMed
  272. Fielding C, et al. 2022. Nat Commun. 13:543. PubMed
  273. Hirako N, et al. 2014. PLoS One. 9:103282. PubMed
  274. Chen Z, et al. 2016. Innate Immunity. 22: 419 - 432. PubMed
  275. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  276. Evavold CL, et al. 2021. Cell. 184(17):4495-4511.e19. PubMed
  277. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  278. Wunderlich CM, et al. 2018. Nat Commun. 9:1646. PubMed
  279. Arima Y et al. 2017. eLife. 6 pii: e25517. PubMed
  280. Hong Y, et al. 2019. J Extracell Vesicles. 8:1670893. PubMed
  281. Zhang M, et al. 2019. Autophagy. 1.423611111. PubMed
  282. Wang K, et al. 2021. Nat Commun. 12:4558. PubMed
  283. Henkle TR, et al. 2021. Cancer Res. 81:4560. PubMed
  284. Gawish R, et al. 2022. Elife. 11:. PubMed
  285. Wang T, et al. 2022. Int J Nanomedicine. 17:2191. PubMed
  286. Nabekura T, et al. 2020. Immunity. 96:52. PubMed
  287. Wong PP, et al. 2020. Cell. 181(6):1346-1363.e21. PubMed
  288. Guo S, et al. 2021. Frontiers in Immunology. 11:614667. PubMed
  289. Scharenberg SG, et al. 2020. Nat Commun. 2.76875. PubMed
  290. K K, et al. 2016. Haematologica. 151159. PubMed
  291. Han J, et al. 2015. Cancer Res . 75: 5273 - 5282. PubMed
  292. Cai W, et al. 2019. J Neuroinflammation. 0.788194444. PubMed
  293. Fernando N, et al. 2020. Front Cell Dev Biol. 0.691666667. PubMed
  294. Dougan M, et al. 2018. Cancer Immunol Res. 6:389. PubMed
  295. Abdel Malik R, et al. 2017. Circ Res. 120:99. PubMed
  296. Saber M, et al. 2021. J Neurotrauma. 38:2862. PubMed
  297. Sethuraman SN, et al. 2020. Theranostics. 10:3397. PubMed
  298. Zhang SJ, et al. 2021. Adv Sci (Weinh). 8:2003410. PubMed
  299. Steinmetz TD, et al. 2021. Autophagy. 17:2238. PubMed
  300. Hohsfield LA, et al. 2021. Elife. 10:. PubMed
  301. Kaya-Tilki E, et al. 2021. PLoS One. 16:e0260633. PubMed
  302. Zhang J, et al. 2021. Stem Cell Res Ther. 12:579. PubMed
  303. Amend A, et al. 2021. Int J Mol Sci. 22:. PubMed
  304. Rana MN, et al. 2021. Front Pharmacol. 12:643215. PubMed
RRID
AB_312790 (BioLegend Cat. No. 101207)
AB_312791 (BioLegend Cat. No. 101208)

Antigen Details

Structure
Integrin family, associates with integrin β2 (CD18), 170 kD
Distribution

Granulocytes, monocytes/macrophages, dendritic cells, NK cells, subsets of T and B cells

Function
Adhesion, chemotaxis
Ligand/Receptor
ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, fibrinogen
Cell Type
B cells, Dendritic cells, Granulocytes, Macrophages, Monocytes, Neutrophils, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Coxon A, et al. 1996. Immunity 5:653.

Gene ID
16409 View all products for this Gene ID 3684 View all products for this Gene ID
UniProt
View information about CD11b on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.

Other Formats

View All CD11b Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse/human CD11b M1/70 FC
Biotin anti-mouse/human CD11b M1/70 FC
FITC anti-mouse/human CD11b M1/70 FC
PE anti-mouse/human CD11b M1/70 FC,IHC
PE/Cyanine5 anti-mouse/human CD11b M1/70 FC
Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,IHC-F,ICC
PE/Cyanine7 anti-mouse/human CD11b M1/70 FC
Alexa Fluor® 488 anti-mouse/human CD11b M1/70 FC,IHC-F,3D IHC,SB
Alexa Fluor® 647 anti-mouse/human CD11b M1/70 FC,3D IHC,SB
Alexa Fluor® 700 anti-mouse/human CD11b M1/70 FC
Pacific Blue™ anti-mouse/human CD11b M1/70 FC
APC/Cyanine7 anti-mouse/human CD11b M1/70 FC
PerCP/Cyanine5.5 anti-mouse/human CD11b M1/70 FC
PerCP anti-mouse/human CD11b M1/70 FC
Brilliant Violet 421™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 570™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 605™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 650™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 711™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 785™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 510™ anti-mouse/human CD11b M1/70 FC,ICC
Ultra-LEAF™ Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,Block,Depletion,IHC-F,ICC
Purified anti-mouse/human CD11b (Maxpar® Ready) M1/70 FC,CyTOF®
Alexa Fluor® 594 anti-mouse/human CD11b M1/70 IHC-F,FC
PE/Dazzle™ 594 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 750 anti-mouse/human CD11b M1/70 FC
TotalSeq™-A0014 anti-mouse/human CD11b M1/70 PG
Brilliant Violet 750™ anti-mouse/human CD11b M1/70 FC
TotalSeq™-B0014 anti-mouse/human CD11b M1/70 PG
TotalSeq™-C0014 anti-mouse/human CD11b M1/70 PG
Spark NIR™ 685 anti-mouse/human CD11b M1/70 FC
PE/Fire™ 640 anti-mouse/human CD11b M1/70 FC
Spark YG™ 593 anti-mouse/human CD11b M1/70 FC
Spark YG™ 570 anti-mouse/human CD11b M1/70 IHC-F
PE/Fire™ 810 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 810 anti-mouse/human CD11b Antibody M1/70 FC
Spark Blue™ 550 anti-mouse/human CD11b M1/70 FC
Spark UV™ 387 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 806 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 780 anti-mouse/human CD11b M1/70 FC
Spark Blue™ 574 anti-mouse/human CD11b (Flexi-Fluor™) M1/70 FC
Spark PLUS UV™ 395 anti-mouse/human CD11b M1/70 FC
Go To Top Version: 2    Revision Date: 03/14/2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account